Brief: ABVC BioPharma Says Phase II Vitargus Clinical Study Protocol Gets Local Ethics Committee Approval

ABVC Biopharma

02/08/2022 14:25

Aug 2 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA PROVIDES VITARGUS® UPDATE
    * ABVC BIOPHARMA INC - PHASE II VITARGUS CLINICAL STUDY
PROTOCOL
RECEIVES LOCAL ETHICS COMMITTEE APPROVAL
    * ABVC BIOPHARMA INC - VITARGUS PHASE II CLINICAL STUDY
PROTOCOL
DOCUMENTS ARE NOW UNDER REVIEW BY AUSTRALIAN BELLBERRY HUMAN
RESEARCH ETHICS COMMITTEE
    * ABVC BIOPHARMA INC - UPON TGA APPROVAL, CLINICAL TRIAL
WILL
BEGIN IN AUSTRALIA AT PREVIOUSLY SELECTED SITES

Source text for Eikon:  ID:nGNX8SyKDJ 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com;))